FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Human Radiolabeled Mass Balance Study Guide

[ Price : $8.95]

FDA publishes a guidance with recommendations on clinical pharmacology considerations for conducting human radiolabeled mass balan...

Guide on Blood Pressure Donor Eligibility

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Blood Pressure and Pulse Donor Eligibility Requirements: Co...

Baxter Recalls Volara System Ventilator Adapter

[ Price : $8.95]

Baxter International recalls (Class 1) certain lots of the Volara system single-patient use circuit and blue ventilator adapter as...

Comments Extended for Guide on Platform Technology

[ Price : $8.95]

Federal Register notice: FDA extends the comment period on its draft guidance entitled Platform Technology Designation Program for...

FDA Opening Rare Disease Innovation Hub

[ Price : $8.95]

CDER director Patrizia Cavazzoni and CBER director Peter Marks say they are co-leading a new FDA Rare Disease Innovation Hub.

Blood Donor Eligibility Compliance Policy

[ Price : $8.95]

FDA publishes a guidance with its compliance policy about blood establishments failing to comply with some donor eligibility requi...

Endo Recalls 1 Lot of Clonazepam

[ Price : $8.95]

Endo recalls (Class 1) one lot of clonazepam orally disintegrating tablets 0.25 mg due to mislabeling on the cartons of some packs...

Hyperfine AI Swoop MR Software Cleared

[ Price : $8.95]

FDA clears a Hyperfine 510(k) for the ninth generation of artificial intelligence-powered Swoop magnetic resonance software.

Bayer Looking to Expand Nubeqa Indication

[ Price : $8.95]

Bayer says it will present positive results from a Phase 3 Nubeqa prostate cancer trial to FDA to consider a potential indication ...

Priority Review for Atara Gene Therapy

[ Price : $8.95]

FDA accepts for priority review an Atara Biotherapeutics BLA for gene therapy tabelecleucel, indicated as monotherapy for treating...